These results may be considered logical because in those conditions, tyrosinase is completely inhibited and the possible inhibitory effect of glutathione cannot act because no orthodiquinones are produced
Shared decision-making should weigh the established benefits of semaglutide for diabetes control and weight management against theoretical thyroid risks, particularly in patients with multiple cardiovascular risk factors who stand to benefit substantially from treatment
Many patients who experience plateau benefit from dose increases that re-engage the GLP-1 pathway at a higher level of receptor stimulation
1,2 While outcome in intensively treated individuals was superior to those undergoing standard therapy, of concern was the weight gain and increased risk of hypoglycemia
Iriarte and colleagues at George Washington documented this expanding evidence base in their 2017 Clinical, Cosmetic and Investigational Dermatology review, cataloguing the technique across acne scars, alopecia, melasma, photoaging, and drug delivery applications [3]